ELAN 8-K 2026-11-06

Elanco Animal Health Inc (ELAN) 8-K dated 2026-11-06 — accession 0001739104-26-000054.

Elanco Animal Health Inc (ELAN) is a drug manufacturers - specialty & generic company listed on US.

Elanco Animal Health Inc filed a 8-K on 2026-11-06. Accession 0001739104-26-000054.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported ELAN revenue for 2025-12-31 was $4.71B. Net income was -$232.0M. Revenue was up 6.2% from 2024-12-31 to 2025-12-31. ELAN currently screens at market cap $11.80B.

Not investment advice. The ELAN SEC hub lists recent forms. The stock page is the research view.